Found: 10
Select item for more details and to access through your institution.
Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1254, doi. 10.1002/ajh.26991
- By:
- Publication type:
- Article
Salvage therapy with basiliximab and etanercept for severe steroid‐refractory acute graft‐versus‐host disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E273, doi. 10.1002/ajh.26568
- By:
- Publication type:
- Article
Risk of invasive fungal infections in patients with high‐risk MDS and AML receiving hypomethylating agents.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 792, doi. 10.1002/ajh.25808
- By:
- Publication type:
- Article
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 12, p. 2003, doi. 10.1093/cid/ciy822
- By:
- Publication type:
- Article
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration.
- Published in:
- 2020
- By:
- Publication type:
- journal article
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 802, doi. 10.1177/10781552231189199
- By:
- Publication type:
- Article
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 892, doi. 10.1177/10781552221080710
- By:
- Publication type:
- Article
Cancer immunotherapy comes of age and looks for maturity.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17140-5
- By:
- Publication type:
- Article
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 714, p. 1, doi. 10.1126/scitranslmed.adi1145
- By:
- Publication type:
- Article
Good CARMA: Turning bad tumor‐resident myeloid cells good with chimeric antigen receptor macrophages.
- Published in:
- Immunological Reviews, 2023, v. 320, n. 1, p. 236, doi. 10.1111/imr.13231
- By:
- Publication type:
- Article